Evidence map›Paper›PMID 24945755›Full record

ArticleToxins2014

Cloning and characterization of a unique cytotoxic protein parasporin-5 produced by Bacillus thuringiensis A1100 strain.

Keisuke Ekino, Shiro Okumura, Tomoyuki Ishikawa, Sakae Kitada, Hiroyuki Saitoh, Tetsuyuki Akao, Takuji Oka, Yoshiyuki Nomura, Michio Ohba, Takashi Shin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Complete genome sequence ofMicrobiology resource announcements · 2026
    Article
  2. Review
  3. Article
  4. Genetic Modification Approaches for ParasporinsMolecules (Basel, Switzerland) · 2021
    Review
  5. Parasporin A13-2 ofToxins · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Differentiation ofFrontiers in microbiology · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Keisuke EkinoDepartment of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan. ekino@bio.sojo-u.ac.jp.
Shiro OkumuraBiotechnology and Food Research Institute, Fukuoka Industrial Technology Center, 1465-5 Aikawa-machi, Kurume, Fukuoka 839-0861, Japan. sokumura@fitc.pref.fukuoka.jp.
Tomoyuki IshikawaBiotechnology and Food Research Institute, Fukuoka Industrial Technology Center, 1465-5 Aikawa-machi, Kurume, Fukuoka 839-0861, Japan. tishikawa@fitc.pref.fukuoka.jp.
Sakae KitadaDepartment of Bioscience and Bioinfomatics, Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan. kitada@bio.kyutech.ac.jp.
Hiroyuki SaitohBiotechnology and Food Research Institute, Fukuoka Industrial Technology Center, 1465-5 Aikawa-machi, Kurume, Fukuoka 839-0861, Japan. saitou@fitc.pref.fukuoka.jp.
Tetsuyuki AkaoBiotechnology and Food Research Institute, Fukuoka Industrial Technology Center, 1465-5 Aikawa-machi, Kurume, Fukuoka 839-0861, Japan. akao@fitc.pref.fukuoka.jp.
Takuji OkaDepartment of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan. oka@bio.sojo-u.ac.jp.
Yoshiyuki NomuraDepartment of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan. nomura@bio.sojo-u.ac.jp.
Michio OhbaGraduate School of Agriculture, Kyushu University, Fukuoka 812-8581, Japan. gunka@yk2.so-net.ne.jp.
Takashi ShinDepartment of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan. shin@bio.sojo-u.ac.jp.
Eiichi MizukiBiotechnology and Food Research Institute, Fukuoka Industrial Technology Center, 1465-5 Aikawa-machi, Kurume, Fukuoka 839-0861, Japan. emizuki@fitc.pref.fukuoka.jp.
Fukuoka Industrial Technology Center · JPSojo University · JPKyushu Institute of Technology · JPKyushu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parasporin is the cytocidal protein present in the parasporal inclusion of the non-insecticidal Bacillus thuringiensis strains, which has no hemolytic activity but has cytocidal activities, preferentially killing cancer cells. In this study, we characterized a cytocidal protein that belongs to this category, which was designated parasporin-5 (PS5). PS5 was purified from B. thuringiensis serovar tohokuensis strain A1100 based on its cytocidal activity against human leukemic T cells (MOLT-4). The 50% effective concentration (EC₅₀) of PS5 to MOLT-4 cells was approximately 0.075 μg/mL. PS5 was expressed as a 33.8-kDa inactive precursor protein and exhibited cytocidal activity only when degraded by protease at the C-terminal into smaller molecules of 29.8 kDa. Although PS5 showed no significant homology with other known parasporins, a Position Specific Iterative-Basic Local Alignment Search Tool (PSI-BLAST) search revealed that the protein showed slight homology to, not only some B. thuringiensis Cry toxins, but also to aerolysin-type β-pore-forming toxins (β-PFTs). The recombinant PS5 protein could be obtained as an active protein only when it was expressed in a precursor followed by processing with proteinase K. The cytotoxic activities of the protein against various mammalian cell lines were evaluated. PS5 showed strong cytocidal activity to seven of 18 mammalian cell lines tested, and low to no cytotoxicity to the others.

Indexed as

AnimalsAntineoplastic AgentsBacillus thuringiensisBacterial ProteinsCell LineCell Line, TumorCell SurvivalChlorocebus aethiopsCricetulusEndopeptidase KEndotoxinsHumansMiceMolecular WeightOsmolar ConcentrationPeptide FragmentsAntineoplastic AgentsBacterial ProteinsEndopeptidase KEndotoxinsparasporin 5, Bacillus thuringiensisPeptide FragmentsProtein IsoformsRecombinant Proteins

Identifiers

PMID24945755
PMCPMC4073135
OpenAlexW2044851161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.